CV Sciences (CVSI)

Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

CV Sciences, Inc. (the “Registrant”) held its 2021 Annual Meeting of Stockholders on May 27, 2021 (the “2021 Annual Meeting”). At the close of business on March 29, 2021, the record date for the 2021 Annual Meeting, there were 106,791,238 shares of common stock issued and outstanding, which constituted all of the outstanding capital stock of the Registrant. At the 2021 Annual Meeting, 57,073,846 of the 106,791,238 outstanding shares of common stock entitled to vote, or approximately 53%, were represented by proxy, and, therefore, a quorum was present. The proposals voted on at the 2021 Annual Meeting are more fully described in the Proxy Statement on Schedule 14A filed by the Registrant with the Securities and Exchange Commission (the “Commission”) on April 8, 2021, and are incorporated by reference herein.

The final voting results on the proposals presented for stockholder approval at the 2021 Annual Meeting were as follows:

Proposal 1 - Election of Directors

The Registrant’s stockholders elected five directors, each to serve until the Registrant’s next Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, as set forth below:

Beth Altman14,485,6164,160,97838,427,252
Dr. Paul Blake14,355,9354,290,65938,427,252
Joseph Dowling10,663,6467,982,94838,427,252
Dr. Joseph Maroon14,422,9624,223,63238,427,252
Terri Funk Graham14,320,5874,326,00738,427,252

Proposal 2 - Approval to Increase Authorized Shares

The Registrant’s stockholders did not approve the Registrant's proposal to amend its Certificate of Incorporation, as amended (the "Existing Charter"), to increase the number of authorized shares of common stock from 190,000,000 to 290,000,000 shares, and to correspondingly increase the number of authorized shares of all classes of capital stock to 300,000,000 shares (the "Proposed Charter Amendment"), as set forth below:


As a result, the Existing Charter shall remain in place and the Registrant will not effectuate the Proposed Charter Amendment.

Proposal 3 - Ratification of Selection of Independent Registered Public Accounting Firm

The Registrant’s stockholders ratified Deloitte & Touche LLP as the Registrant's independent registered public accounting firm for the fiscal year ending December 31, 2021, as set forth below:



Proposal 4 - Advisory Vote to Approve Named Executive Officer Compensation

The Registrant’s stockholders did not approve an advisory, non-binding vote on compensation programs for its named executive officers, Mr. Joseph Dowling, Mr. Joerg Grasser, and Dr. Duffy MacKay, as disclosed pursuant to